Closed System Transfer Devices for Drug Preparation


April 2011 : State of Pharmacy Compounding - Vol. 8 No. 4 - Page #14

Recognizing the safety risks in hazardous drug transfer, 44% of facilities have incorporated closed system transfer devices (CSTDs) into the compounding process. Those who have not adopted CSTDs cited budget constraints as the most common reason for not doing so. 

For more information on closed system transfer devices, visit www.pppmag.com/info and click on Closed System Transfer Devices.

To view the PDF, click the download link above.

Login

Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Recent Popular Articles

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: